Abstract：
Clostridioides difficile (C. difficile) is a major nosocomial pathogen but is also increasingly recognised as an important diarrhoeal pathogen in the community, not always associated with antibiotics. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for C. difficile (ESGCD) is a group of clinicians, scientists, and others from many European countries and further afield, who share a common interest in C. difficile. The aims of the Study Group are centred around raising the profile of C. difficile infection (CDI) in humans and animals, fostering collaboration amongst centres in different European countries and providing a forum for discussing and disseminating information. One of the principal aims of the Study Group is to raise awareness of C. difficile infections in Europe. ESGCD has a particular interest in the development and dissemination of European guidance on prevention, diagnosis, and treatment of CDI. This chapter will discuss the organisation of ESGCD within the ESCMID Study Group structure, the origins of the Study Group, the aims, and objectives of the group, and will highlight some of the past and present activities of ESGCD in relation to these.
摘要：
艰难梭菌(C.difficile）是一种主要的医院病原体，但在社区中也越来越被认为是一种重要的腹泻病原体，并不总是与抗生素有关。欧洲临床微生物学和传染病学会（ESCMID）艰难梭菌研究小组（ESGCD）是一组临床医生，科学家,以及来自许多欧洲国家和更远地区的其他人，他们对艰难梭菌有着共同的兴趣。研究组的目标集中在提高人类和动物的艰难梭菌感染（CDI）的形象，促进不同欧洲国家中心之间的合作，并提供一个讨论和传播信息的论坛。研究小组的主要目标之一是提高欧洲对艰难梭菌感染的认识。ESGCD对制定和传播欧洲预防指南特别感兴趣，诊断,和CDI的治疗。本章将讨论ESCMID研究组结构中的ESGCD组织，研究组的起源，目标,和小组的目标，并将重点介绍ESGCD过去和现在的一些活动。
